Tailored Angiogenesis Inhibition in Cancer Therapy: Respecting the Heart to Improve the Net Outcome

Publisher： Bentham Science Publishers

E-ISSN： 2212-389x|7|3|265-288

ISSN： 1574-3624

Source： Current Signal Transduction Therapy, Vol.7, Iss.3, 2012-09, pp. : 265-288

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Does Guideline-Adherent Therapy Improve the Outcome for Early-Onset Breast Cancer Patients?

By  

Oncology, Vol. 78, Iss. 3-4, 2010-04 ,pp. : 189-195

Karger

Access to resources Recommend Favorite

Outcome of Adjuvant Therapy for Gallbladder Cancer

By  

Oncology, Vol. 79, Iss. 3-4, 2010-12 ,pp. : 168-173

Karger

Access to resources Recommend Favorite

Outcome Studies with Device Therapy in Patients with Heart Failure

By  

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, Vol. 13, Iss. S1, 2002-01 ,pp. : S73-S91

John Wiley & Sons Inc

Access to resources Recommend Favorite

Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy

By Fredolini Claudia   Liotta Lance A.   Petricoin Emanuel F.  

Critical Reviews in Clinical Laboratory Sciences, Vol. 47, Iss. 3, 2010-06 ,pp. : 125-138

Informa Healthcare

Access to resources Recommend Favorite

Past, present and future of gene expression-tailored therapy for lung cancer

By Marrer Estelle   Baty Florent   Kehren Jeanne   Chibout Salah-Dine   Brutsche Martin  

Personalized Medicine, Vol. 3, Iss. 2, 2006-05 ,pp. : 165-175

Future Medicine

Access to resources Recommend Favorite